1–Alpha, 25–Dihydroxyvitamin D3 Regresses Endometriotic Implants in Rats by Inhibiting Neovascularization and Altering Regulation of Matrix Metalloproteinase

References

• . Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–1799
   PubMed Web of Science ®Google Scholar
• . Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012;39(4):535–549
   PubMed Web of Science ®Google Scholar
• . Osuga Y. Current concepts of the pathogenesis of endometriosis. Reprod Med Biol. 2010;9:1–7
   PubMedGoogle Scholar
• . Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod. 1996;11( Suppl 2):124–133
   PubMed Web of Science ®Google Scholar
• . Osteen KG, Yeaman GR, Bruner-Tran KL. Matrix metalloproteinases and endometriosis. Semin Reprod Med. 2003;21(2):155–164
   PubMedGoogle Scholar
• . Collette T, Bellehumeur C, Kats R, . Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod. 2004;19(6):1257–1264
   PubMed Web of Science ®Google Scholar
• . Huang HF, Hong LH, Tan Y, Sheng JZ. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril. 2004;81(5):1235–1239
   PubMed Web of Science ®Google Scholar
• . Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74(2):111–122
   PubMed Web of Science ®Google Scholar
• . Chung HW, Lee JY, Moon HS, . Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril. 2002;78(4):787–795
   PubMed Web of Science ®Google Scholar
• . Uzan C, Cortez A, Dufournet C, Fauvet R, Siffroi JP, Daraï E. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases−2, −3 and −11, and of tissue inhibitor metalloproteinases−1 and −2. Virchows Arch. 2004;445(6):603–609
   PubMed Web of Science ®Google Scholar
• . Vanoirbeek E, Krishnan A, Eelen G, . The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3. Best Pract Res Clin Endocrinol Metab. 2011;25(4):593–604
   PubMed Web of Science ®Google Scholar
• . Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res. 2000;87(3):214–220
   PubMed Web of Science ®Google Scholar
• . Agic A, Xu H, Altgassen C, . Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007;14(5):486–497
   PubMed Web of Science ®Google Scholar
• . Chung I, Han G, Seshadri M, . Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res. 2009;69(3):967–975
   PubMedGoogle Scholar
• . Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. 1 alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther. 2007;6(4):1433–1439
   PubMedGoogle Scholar
• . Mariani M, Viganò P, Gentilini D, . The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod. 2012;27(7):2010–2019
   PubMed Web of Science ®Google Scholar
• . Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694
   PubMedGoogle Scholar
• . Lebovic DI, Kir M, Casey CL. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril. 2004;82( Suppl 3):1008–1013
   PubMed Web of Science ®Google Scholar
• . Güney M, Oral B, Karahan N, Mungan T. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril. 2008;89(4):934–942
   PubMedGoogle Scholar
• . McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS Sr. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716–721
   PubMed Web of Science ®Google Scholar
• . Taylor HS, Osteen KG, Bruner-Tran KL, . Novel therapies targeting endometriosis. Reprod Sci. 2011;18(9):814–823
   PubMedGoogle Scholar
• . Nasu K, Yuge A, Tsuno A, Narahara H. Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. Fertil Steril. 2009;92(6):2097–2099
   PubMed Web of Science ®Google Scholar
• . Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–496
   PubMed Web of Science ®Google Scholar
• . Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol. 2010;321(2):103–111
   PubMedGoogle Scholar
• . Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Lymphocytes in endometriosis. Am J Reprod Immunol. 2011;65(1):1–10
   PubMedGoogle Scholar
• . Ferrero S, Gillott DJ, Anserini P, . Vitamin D binding protein in endometriosis. J Soc Gynecol Investig. 2005;12(4):272–277
   PubMedGoogle Scholar
• . Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod. 2007;22(8):2273–2278
   PubMed Web of Science ®Google Scholar
• . Vilarino FL, Bianco B, Lerner TG, . Analysis of vitamin D receptor gene polymorphisms in women with and without endometriosis. Hum Immunol. 2011;72(4):359–363
   PubMed Web of Science ®Google Scholar
• . Abbas MA, Taha MO, Disi AM, Shomaf M. Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis. Eur J Pharmacol. 2013;715(1–3):72–75
   PubMed Web of Science ®Google Scholar